J. Elliott Robinson - Publications

Affiliations: 
2008-2016 Neurology/Neurobiology University of North Carolina, Chapel Hill, Chapel Hill, NC 
 2016- Biology & Biological Engineering California Institute of Technology, Pasadena, CA 
Area:
Behavioral pharmacology, autism, alcohol

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Vardy E, Robinson JE, Li C, Olsen RH, DiBerto JF, Giguere PM, Sassano FM, Huang XP, Zhu H, Urban DJ, White KL, Rittiner JE, Crowley NA, Pleil KE, Mazzone CM, et al. A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior. Neuron. 86: 936-46. PMID 25937170 DOI: 10.1016/j.neuron.2015.03.065  1
2015 Robinson JE, Vardy E, DiBerto JF, Chefer VI, White KL, Fish EW, Chen M, Gigante E, Krouse MC, Sun H, Thorsell A, Roth BL, Heilig M, Malanga CJ. Receptor Reserve Moderates Mesolimbic Responses to Opioids in a Humanized Mouse Model of the OPRM1 A118G Polymorphism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 2614-22. PMID 25881115 DOI: 10.1038/npp.2015.109  1
2015 Bilbao A, Robinson JE, Heilig M, Malanga CJ, Spanagel R, Sommer WH, Thorsell A. A pharmacogenetic determinant of mu-opioid receptor antagonist effects on alcohol reward and consumption: evidence from humanized mice. Biological Psychiatry. 77: 850-8. PMID 25442002 DOI: 10.1016/j.biopsych.2014.08.021  1
2015 White KL, Robinson JE, Zhu H, DiBerto JF, Polepally PR, Zjawiony JK, Nichols DE, Malanga CJ, Roth BL. The G protein-biased κ-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo. The Journal of Pharmacology and Experimental Therapeutics. 352: 98-109. PMID 25320048 DOI: 10.1124/jpet.114.216820  1
2015 Nash KR, Moran P, Finneran DJ, Hudson C, Robinson J, Morgan D, Bickford PC. Fractalkine over expression suppresses α-synuclein-mediated neurodegeneration. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 17-23. PMID 25195598 DOI: 10.1038/mt.2014.175  1
2014 Fish EW, DiBerto JF, Krouse MC, Robinson JE, Malanga CJ. Different contributions of dopamine D1 and D2 receptor activity to alcohol potentiation of brain stimulation reward in C57BL/6J and DBA/2J mice. The Journal of Pharmacology and Experimental Therapeutics. 350: 322-9. PMID 24917543 DOI: 10.1124/jpet.114.216135  1
2014 Fish EW, Whitman BJ, DiBerto JF, Robinson JE, Morrow AL, Malanga CJ. Effects of the neuroactive steroid allopregnanolone on intracranial self-stimulation in C57BL/6J mice. Psychopharmacology. 231: 3415-23. PMID 24810108 DOI: 10.1007/s00213-014-3600-8  1
2014 Shaffer JG, Grant DS, Schieffelin JS, Boisen ML, Goba A, Hartnett JN, Levy DC, Yenni RE, Moses LM, Fullah M, Momoh M, Fonnie M, Fonnie R, Kanneh L, Koroma VJ, ... ... Robinson JE, et al. Lassa fever in post-conflict sierra leone. Plos Neglected Tropical Diseases. 8: e2748. PMID 24651047 DOI: 10.1371/journal.pntd.0002748  0.56
2014 Fish EW, Agoglia AE, Krouse MC, Muller RG, Robinson JE, Malanga CJ. Levetiracetam results in increased and decreased alcohol drinking with different access procedures in C57BL/6J mice. Behavioural Pharmacology. 25: 61-70. PMID 24322822 DOI: 10.1097/FBP.0000000000000019  1
2013 Fish EW, Krouse MC, Stringfield SJ, Diberto JF, Robinson JE, Malanga CJ. Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of fragile X syndrome. Plos One. 8: e77896. PMID 24205018 DOI: 10.1371/journal.pone.0077896  1
2013 Robinson JE, Chen M, Stamatakis AM, Krouse MC, Howard EC, Faccidomo S, Hodge CW, Fish EW, Malanga CJ. Levetiracetam has opposite effects on alcohol- and cocaine-related behaviors in C57BL/6J mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1322-33. PMID 23353709 DOI: 10.1038/npp.2013.30  1
2012 Robinson JE, Agoglia AE, Fish EW, Krouse MC, Malanga CJ. Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: comparison to cocaine. Behavioural Brain Research. 234: 76-81. PMID 22728726 DOI: 10.1016/j.bbr.2012.06.012  1
2012 Riday TT, Fish EW, Robinson JE, Jarrett TM, McGuigan MM, Malanga CJ. Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice. Brain Research. 1431: 53-61. PMID 22133306 DOI: 10.1016/j.brainres.2011.11.003  1
2012 Fish EW, Robinson JE, Krouse MC, Hodge CW, Reed C, Phillips TJ, Malanga CJ. Intracranial self-stimulation in FAST and SLOW mice: effects of alcohol and cocaine. Psychopharmacology. 220: 719-30. PMID 21983918 DOI: 10.1007/s00213-011-2523-x  1
2012 Robinson JE, Fish EW, Krouse MC, Thorsell A, Heilig M, Malanga CJ. Potentiation of brain stimulation reward by morphine: effects of neurokinin-1 receptor antagonism. Psychopharmacology. 220: 215-24. PMID 21909635 DOI: 10.1007/s00213-011-2469-z  1
2011 Diatchenko L, Robinson JE, Maixner W. Elucidation of mu-Opioid Gene Structure: How Genetics Can Help Predict Responses to Opioids. European Journal of Pain Supplements. 5: 433-438. PMID 22102848 DOI: 10.1016/j.eujps.2011.08.022  0.72
2011 Cippitelli A, Rezvani AH, Robinson JE, Eisenberg L, Levin ED, Bonaventure P, Motley ST, Lovenberg TW, Heilig M, Thorsell A. The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxiety. Alcohol (Fayetteville, N.Y.). 45: 567-76. PMID 21145691 DOI: 10.1016/j.alcohol.2010.09.003  1
2011 Boules M, Oliveros A, Liang Y, Williams K, Shaw A, Robinson J, Fredrickson P, Richelson E. A neurotensin analog, NT69L, attenuates intravenous nicotine self-administration in rats Neuropeptides. 45: 9-16. PMID 21047685 DOI: 10.1016/j.npep.2010.09.003  1
2008 Liang Y, Shaw AM, Boules M, Briody S, Robinson J, Oliveros A, Blazar E, Williams K, Zhang Y, Carlier PR, Richelson E. Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS). The Journal of Pharmacology and Experimental Therapeutics. 327: 573-83. PMID 18689611 DOI: 10.1124/jpet.108.143610  1
2007 Boules M, Iversen I, Oliveros A, Shaw A, Williams K, Robinson J, Fredrickson P, Richelson E. The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat Brain Research. 1127: 90-98. PMID 17113052 DOI: 10.1016/j.brainres.2006.10.025  1
2007 Shaw AM, Boules M, Zhang Y, Williams K, Robinson J, Carlier PR, Richelson E. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050. European Journal of Pharmacology. 555: 30-6. PMID 17109850 DOI: 10.1016/j.ejphar.2006.10.004  1
Show low-probability matches.